Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Don't get hacked! Research shows how much we ignore online warnings

  • Tapeworm found living inside a patient's brain: Worm removed and sequenced

  • E-cigarettes significantly reduce tobacco cravings, study suggests

  • Coping strategies therapy significantly improves dementia carers' mental health, quality of life

  • Fathers' engagement with baby depends on mother

  • Unstable child care can affect children by age four

  • Self-regulation intervention boosts school readiness of at-risk children, study shows

  • Rejecting unsuitable suitors is easier said than done

  • Reported opioid abuse in pregnant women more than doubles in 14 years

  • Computerized cognitive training has modest benefits for cognitively healthy older adults

  •